S
SPH Health Commerce
An online pharmacy and hospital in China
About SPH Health Commerce
SPH Health Commerce, officially known as Shanghai医药大健康云商股份有限公司, was established in Shanghai in March 2015 as an "Internet+" pharmaceutical commercial technology platform incubated and supported by Shanghai Pharmaceuticals Holding Co., Ltd. The company was founded through a mixed-ownership model involving Shanghai Pharmaceuticals and its management team. A significant milestone was achieved in August 2015 with the completion of its A-round financing, raising over 1.112 billion RMB and bringing in strategic investors like JD.com and IDG Capital. Subsequent financing includes a Series B round in 2021, which raised over 1.033 billion RMB, introduced biopharmaceutical industry funds, and set the stage for a future IPO.
Read full description
The firm operates as a prescription drug O2O (online-to-offline) e-commerce company, focusing on a patient-centered model. Its business is structured around the "Yiyao" (益药) integrated brand, which provides services for the entire life cycle of innovative drugs and "Internet+" services for common and chronic disease medications. The business model is centered on the flow of electronic prescriptions, connecting patients with a network of professional pharmacies. It serves a diverse client base that includes pharmaceutical companies, hospitals, patients, and government and medical institutions by providing digital marketing, patient services, and innovative payment solutions. Revenue is generated through these comprehensive commercialization solutions, covering the spectrum from clinical R&D to the post-launch market.
The company's core service is a platform that integrates online solutions with offline retail resources. This platform is built on three pillars: "electronic prescriptions," "drug data," and "patient data." A key feature is the "Yiyao · Pharmacy" network, which includes over 200 professional pharmacies across 66 cities in China. This network facilitates Direct-to-Patient (DTP) services for new and specialty drugs. Through its "Yiyao · Cloud Pharmacy," the company handles the verification, dispensing, and delivery of prescriptions from its electronic platform. SPH Health Commerce offers comprehensive commercialization solutions for pharmaceutical companies, from clinical trial support to market access and digital marketing, and provides patients with services such as medication counseling, cold chain logistics, and access to patient assistance programs.
At a glance
- Status
- Operational
- Founded
- 2015
- Headquarters
- Xuhui District, China
- Employees
- 8
- Open positions
- None listed
- Dealroom signal
- 38.7/100
- Industry
- Health
- Sub-industry
- Health Platform
- Sector
- Health Tech & Medtech, Pharmacy, Direct-to-Consumer, Tech for Patients, Hard Tech
- Client focus
- b2b, b2c
Latest news
Press, funding announcements and product moves mentioning SPH Health Commerce.
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES COther financing | Oct 2023 | $68M | $799M | SHC Shanghai Biomedical Fund · Industrial and Commercial Bank of China · Chinese Reform Holdings Corporation | ↗ |
| SERIES BOther financing | Feb 2021 | $160M | $639M | Shanghai Biomedical Industrial Equity Investment Fund · New Alliance Capital · Sinocare · Shanghai International Group | — |
Growth signals
Latest recorded traffic for SPH Health Commerce is 810 monthly website visits, up 252.2% over the last three months. SPH Health Commerce's team grew 14.3% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A11 investors entered at this stage
IDG Capital
SB China Capital
JD.com- SFShanghai Charity Foundation
JIC Investment- SFShanghai Biomedical Industrial Equity Investment Fund
New Alliance Capital
Sinocare
Shanghai International Group
Ample Harvest Finance- HCHuadong Industrial Co
Series B and later3 investors entered at this stage
SHC Shanghai Biomedical Fund
Industrial and Commercial Bank of China- CCChinese Reform Holdings Corporation
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about SPH Health Commerce on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See SPH Health Commerce’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.







